U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07025408) titled 'Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns' on June 10.
Brief Summary: This multicentre, randomised, double-blind, dose-finding, active- and placebo-controlled Phase II clinical trial will evaluate the safety, efficacy, pharmacokinetic profile, and immunogenicity of KJ101 for the debridement of deep second-degree burns. The trial will provide supporting evidence for subsequent Phase III trials.
Study Start Date: June 16
Study Type: INTERVENTIONAL
Condition:
Burn
Burn Wounds - Partial Thickness (2nd Degree)
Intervention:
DRUG: KJ101
1. Clean the wound before applying medication.
2. Apply KJ101 (8...